Cargando…

Recurrent coronary thrombotic events in a moderate case of COVID-19

We describe the case of a healthy patient with moderate COVID-19 infection without thrombophilia nor coronary disease background who presented with a relapsing thrombotic occlusion of the right coronary artery despite normal oxygenation, adequate antiaggregation and prophylactic anticoagulation. Pro...

Descripción completa

Detalles Bibliográficos
Autores principales: Muguerza, Julian, Loizeau, Pierre A
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7843346/
https://www.ncbi.nlm.nih.gov/pubmed/33500300
http://dx.doi.org/10.1136/bcr-2020-237624
_version_ 1783644121697615872
author Muguerza, Julian
Loizeau, Pierre A
author_facet Muguerza, Julian
Loizeau, Pierre A
author_sort Muguerza, Julian
collection PubMed
description We describe the case of a healthy patient with moderate COVID-19 infection without thrombophilia nor coronary disease background who presented with a relapsing thrombotic occlusion of the right coronary artery despite normal oxygenation, adequate antiaggregation and prophylactic anticoagulation. Prophylactic anticoagulation recommendations in COVID-19 were inadequate for this patient. Further data are needed to propose full-dose therapeutic anticoagulation for patients with coronary thrombosis and COVID-19 infection. This could nevertheless be considered even in mild forms of COVID-19.
format Online
Article
Text
id pubmed-7843346
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher BMJ Publishing Group
record_format MEDLINE/PubMed
spelling pubmed-78433462021-01-29 Recurrent coronary thrombotic events in a moderate case of COVID-19 Muguerza, Julian Loizeau, Pierre A BMJ Case Rep Case Report We describe the case of a healthy patient with moderate COVID-19 infection without thrombophilia nor coronary disease background who presented with a relapsing thrombotic occlusion of the right coronary artery despite normal oxygenation, adequate antiaggregation and prophylactic anticoagulation. Prophylactic anticoagulation recommendations in COVID-19 were inadequate for this patient. Further data are needed to propose full-dose therapeutic anticoagulation for patients with coronary thrombosis and COVID-19 infection. This could nevertheless be considered even in mild forms of COVID-19. BMJ Publishing Group 2021-01-26 /pmc/articles/PMC7843346/ /pubmed/33500300 http://dx.doi.org/10.1136/bcr-2020-237624 Text en © BMJ Publishing Group Limited 2021. No commercial re-use. See rights and permissions. Published by BMJ. This article is made freely available for use in accordance with BMJ’s website terms and conditions for the duration of the covid-19 pandemic or until otherwise determined by BMJ. You may use, download and print the article for any lawful, non-commercial purpose (including text and data mining) provided that all copyright notices and trade marks are retained.https://bmj.com/coronavirus/usage
spellingShingle Case Report
Muguerza, Julian
Loizeau, Pierre A
Recurrent coronary thrombotic events in a moderate case of COVID-19
title Recurrent coronary thrombotic events in a moderate case of COVID-19
title_full Recurrent coronary thrombotic events in a moderate case of COVID-19
title_fullStr Recurrent coronary thrombotic events in a moderate case of COVID-19
title_full_unstemmed Recurrent coronary thrombotic events in a moderate case of COVID-19
title_short Recurrent coronary thrombotic events in a moderate case of COVID-19
title_sort recurrent coronary thrombotic events in a moderate case of covid-19
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7843346/
https://www.ncbi.nlm.nih.gov/pubmed/33500300
http://dx.doi.org/10.1136/bcr-2020-237624
work_keys_str_mv AT muguerzajulian recurrentcoronarythromboticeventsinamoderatecaseofcovid19
AT loizeaupierrea recurrentcoronarythromboticeventsinamoderatecaseofcovid19